Back
Akero Therapeutics Stock Price Chart

7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Buy
64
AKRO
Akero Therapeutics
Last Price:
$55.77
Seasonality Move:
13.24%
7 Day Trial
ALL ACCESS PASS
$
7

Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.07 | Buy |
20-day SMA: | 49.61 | Buy |
50-day SMA: | 43.75 | Buy |
200-day SMA: | 36.79 | Buy |
8-day EMA: | 53.49 | Buy |
20-day EMA: | 50.33 | Buy |
50-day EMA: | 46.33 | Buy |
200-day EMA: | 38.56 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.22 | Buy |
Relative Strength Index (14 RSI): | 69.42 | Buy |
Chaikin Money Flow: | 1967952 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.81 - 53.51) | Buy |
Bollinger Bands (100): | (37.5 - 51.86) | Buy |
Akero Therapeutics Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 55.62 while AKRO 8-day simple moving average is 54.07, which is a Buy signal.
-
The stock price of AKRO is 55.62 while Akero Therapeutics 20-day SMA is 49.61, which makes it a Buy.
-
Akero Therapeutics 50-day simple moving average is 43.75 while AKRO share price is 55.62, making it a Buy technically.
-
AKRO stock price is 55.62 and Akero Therapeutics 200-day simple moving average is 36.79, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
64
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a BuyThe current Akero Therapeutics [AKRO] share price is $55.62. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
4.4B
Price in USD:
55.62
Share Volume:
2.2M
Akero Therapeutics 52-Week Range
52-Week High:
58.40
52-Week Low:
21.02
Buy
64
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?The Akero Therapeutics stock price is 55.62 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 55.62 while AKRO 8-day exponential moving average is 53.49, which is a Buy signal.
-
The stock price of AKRO is 55.62 while Akero Therapeutics 20-day EMA is 50.33, which makes it a Buy.
-
Akero Therapeutics 50-day exponential moving average is 46.33 while AKRO share price is 55.62, making it a Buy technically.
-
AKRO stock price is 55.62 and Akero Therapeutics 200-day simple moving average is 38.56, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is 3.22, suggesting Akero Therapeutics is a Buy
-
Akero Therapeutics Relative Strength Index (RSI) is 69.42, which suggest Akero Therapeutics is overbought
-
The Bollinger Bands (25) for Akero Therapeutics is (41.81 - 53.51), which suggest Akero Therapeutics is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics is (37.5 - 51.86), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.